Worldwide News

In response to the data management needs of manufacturing QA/QC and contract laboratories, the latest version of Thermo Scientific’s SampleManager Laboratory Information Management System (LIMS) software offers an advanced solution: a built-in electronic lab notebook (ELN), capabilities to streamline operations within contract laboratories and enhanced dashboard configuration for tailored data visualisation. SampleManager LIMS software 12.3 […]

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a study designed to determine whether certain approved therapies or investigational drugs in late-stage clinical development show promise against COVID-19 and merit advancement into larger clinical trials. The ACTIV-5 Big Effect Trial, which will enrol adult volunteers […]

Blue Oak Pharmaceuticals, an innovator in the discovery of transformative CNS drugs, and Exscientia, a clinical-stage Artificial Intelligence (AI) drug-discovery company, have announced an innovative drug-discovery collaboration to treat brain disorders. This collaboration combines Blue Oak’s therapeutic area expertise and ability to design novel, CNS focused privileged chemotypes with Exscientia’s proven ability to apply AI […]

Axol Bioscience, a biotechnology company specialising in the use of stem cell technology to manufacture disease-relevant cell-based assay systems to the drug discovery industry, has introduced multi-electrode array (MEA) screening for human induced pluripotent stem cell (hiPSC)-derived cells. The new services have been developed to support pre-clinical research by optimising hiPSC-derived cell culture, while providing high-quality […]

Data tech innovator Talking Medicines, which uses advanced AI to provide pharmaceutical companies with real-time data intelligence, has been chosen to join Tech Nation’s Applied AI 2.0 Growth Programme. Tech Nation’s growth programmes are designed to champion and support ‘the UK’s most exceptional deep tech scaleups’ and alumni include Skyscanner, Darktrace, and Monzo. The programme […]

IONTAS, a biotechnology company focused on antibody discovery technology development, has entered into a licensing agreement with Bristol Myers Squibb regarding its proprietary mammalian display. Under the terms of this agreement, IONTAS will receive an upfront payment for accessing the technology platform and will work with Bristol Myers Squibb in establishing the platform within its […]

Mogrify’s EpiMOGRIFY platform models the epigenetic state of the cell to predict the switches important for cell identity, cell maintenance, directed differentiation and cell conversion. EpiMOGRIFY is an extension of the company’s proprietary direct cellular conversion technology, MOGRIFY, and enables the identification of the optimal culture conditions required to maintain cells in chemically defined media. This […]

Adrian van den Hoven, Director General, Medicines for Europe, looks at how COVID-19 has altered the way we consider EU pharmaceutical policy Adrian van den Hoven delivered the opening keynote address at the CPhI Festival of Pharma on how COVID-19 is changing the landscape of European pharmaceutical policy, primarily with regard to supply chain security. […]

Researchers are continually looking for processes and technology that give them the edge scientifically or commercially. If you are a biotech scientist interested in reversing or overcoming the state of T-cell exhaustion, this webinar will be beneficial to your work. Quantifying T cell exhaustion: An insight into BiTE antibodies and CAR-T cells for improved therapeutics will […]

The UK Department for International Trade (DIT) has classified Stevenage in the UK, as a High Potential Opportunity (HPO) zone in recognition of its thriving cell and gene therapy cluster of national and international significance. The successful HPO nomination was made by Hertfordshire Local Enterprise Partnership (LEP) and is expected to help attract further overseas […]